Cargando…

Metabolic disease as a risk of hepatocellular carcinoma

Detalles Bibliográficos
Autor principal:	Nishida, Naoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820215/ https://www.ncbi.nlm.nih.gov/pubmed/33317238 http://dx.doi.org/10.3350/cmh.2020.0302

Ejemplares similares

Long-term prognosis and management of hepatocellular carcinoma after curative treatment
por: Nishida, Naoshi
Publicado: (2020)

Advances in Immunotherapy for Hepatocellular Carcinoma
por: Hagiwara, Satoru, et al.
Publicado: (2023)

Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma: A Systematic Review
por: Nishida, Naoshi, et al.
Publicado: (2011)

Role of Oncogenic Pathways on the Cancer Immunosuppressive Microenvironment and Its Clinical Implications in Hepatocellular Carcinoma
por: Nishida, Naoshi
Publicado: (2021)

Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma
por: Nishida, Naoshi, et al.
Publicado: (2020)

Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma
por: Aoki, Tomoko, et al.
Publicado: (2022)

The role of FGFR inhibitors in the treatment of intrahepatic cholangiocarcinoma—unveiling the future challenges in drug therapy
por: Nishida, Naoshi
Publicado: (2023)

Imaging Diagnosis of Various Hepatocellular Carcinoma Subtypes and Its Hypervascular Mimics: Differential Diagnosis Based on Conventional Interpretation and Artificial Intelligence
por: Minami, Yasunori, et al.
Publicado: (2022)

Targeting the Metabolic Vulnerability of ARID1A-Deficient Hepatocellular Carcinoma
por: Chan, For-Fan, et al.
Publicado: (2022)

Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
por: Tsoulfas, Georgios
Publicado: (2019)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2015)

Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges
por: Lupberger, Joachim, et al.
Publicado: (2021)

Nonzero Risk of Hepatocellular Carcinoma Even after Sustained Virological Response
por: Lee, Hyun Woong
Publicado: (2016)

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
por: Baumert, Thomas F., et al.
Publicado: (2019)

Metabolic syndrome and hepatocellular carcinoma risk
por: Turati, F, et al.
Publicado: (2013)

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
por: Jang, Byoung Kuk
Publicado: (2016)

Welcome to Journal of Hepatocellular Carcinoma
por: Kaseb, Ahmed O
Publicado: (2015)

Molecular heterogeneity in hepatocellular carcinoma
por: Zhu, Shijia, et al.
Publicado: (2018)

Novel Therapies for Hepatocellular Carcinoma
por: Rimassa, Lorenza
Publicado: (2020)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Hot topics in hepatocellular carcinoma
por: Ielasi, Luca, et al.
Publicado: (2019)

Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma
por: Morita, Masahiro, et al.
Publicado: (2023)

Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease
por: Gallo, Paolo, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
por: Song, Byeong Geun, et al.
Publicado: (2023)

Abdominal Ultrasound and Treatment of Hepatocellular Carcinoma
por: Numata, Kazushi
Publicado: (2021)

Noninvasive diagnostic criteria for hepatocellular carcinoma
por: Lee, Han Chu
Publicado: (2012)

Pro-senescence therapy for hepatocellular carcinoma
por: Muehlich, Susanne, et al.
Publicado: (2013)

Role of ncRNAs in Hepatocellular Carcinoma
por: Tu, Kangsheng, et al.
Publicado: (2018)

The Quest for Relevant Hepatocellular Carcinoma Biomarkers
por: Kim, Jin U., et al.
Publicado: (2017)

Hepatocellular Carcinoma: Special Issue Highlights
por: Gupta, Medhavi, et al.
Publicado: (2020)

Combination of biomarkers for the detection of hepatocellular carcinoma
por: Sternby Eilard, Malin, et al.
Publicado: (2020)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
por: Ren, Zhigang, et al.
Publicado: (2020)

Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
por: Eso, Yuji
Publicado: (2020)

Recent Advancements for the Treatment of Hepatocellular Carcinoma
por: Nouso, Kazuhiro
Publicado: (2023)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
por: Hagiwara, Satoru, et al.
Publicado: (2021)

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Teng, Margaret L. P., et al.
Publicado: (2022)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
por: Teng, Margaret LP, et al.
Publicado: (2023)

Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
por: Lee, Chang Hun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g9ibd7m1snqkqeggke0ugmr8rd